US Stock MarketDetailed Quotes
RGNX Regenxbio
- 7.400
- +0.020+0.27%
Close Dec 24 13:00 ET
- 7.400
- 0.0000.00%
Post 13:01 ET
366.63MMarket Cap-1.48P/E (TTM)
7.560High7.245Low344.20KVolume7.420Open7.380Pre Close2.55MTurnover0.85%Turnover RatioLossP/E (Static)49.55MShares28.80052wk High1.22P/B300.44MFloat Cap7.15052wk Low--Dividend TTM40.60MShs Float85.100Historical High--Div YieldTTM4.27%Amplitude7.070Historical Low7.409Avg Price1Lot Size
Regenxbio Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 17.93%-40.55M | 3.86%-45.5M | 31.47%-55.46M | -5.26%-218.41M | -3.53%-40.76M | 2.08%-49.41M | 23.36%-47.32M | -44.73%-80.92M | -194.80%-207.49M | -111.53%-39.37M |
| Net income from continuing operations | 3.67%-59.6M | 26.47%-52.99M | 5.02%-63.33M | 6.00%-263.49M | -4.93%-62.89M | 18.04%-61.87M | -5.69%-72.06M | 13.10%-66.68M | -319.27%-280.32M | -120.38%-59.94M |
| Operating gains losses | ---- | ---- | ---- | -2,891.14%-2.21M | --0 | ---- | ---- | ---- | 101.52%79K | --0 |
| Depreciation and amortization | -9.40%3.96M | -8.66%4.05M | 0.05%4.18M | 34.17%17.32M | 5.07%4.34M | 23.19%4.37M | 67.80%4.44M | 61.25%4.18M | 34.97%12.91M | 58.33%4.13M |
| Other non cash items | -45.85%450K | -1.42%-715K | 188.65%617K | -125.82%-95K | 170.37%475K | 669.44%831K | -169.25%-705K | -738.55%-696K | -91.56%368K | -386.02%-675K |
| Change In working capital | 1,074.16%6.07M | -139.86%-4.04M | 72.45%-8.16M | -177.89%-10.89M | 35.61%9.22M | -106.24%-623K | 214.33%10.13M | -589.94%-29.61M | -65.25%13.98M | -83.85%6.8M |
| -Change in receivables | 89.15%-710K | -188.77%-6.89M | -3.35%9.18M | -18.39%3.94M | -30.45%3.37M | -230.68%-6.54M | 77.73%-2.39M | 66.90%9.5M | -65.85%4.82M | -77.99%4.84M |
| -Change in prepaid assets | -138.46%-981K | 772.62%3.57M | 157.37%930K | -112.78%-620K | -312.01%-1.96M | 79.52%2.55M | -82.19%409K | -871.90%-1.62M | 158.83%4.85M | 363.25%924K |
| -Change in payables and accrued expense | 82.71%9.23M | -167.88%-5.39M | 53.54%-8.62M | 95.03%-339K | 15.14%5.22M | 7.26%5.05M | 225.06%7.94M | -90.84%-18.55M | -124.73%-6.83M | -78.03%4.53M |
| -Change in other current assets | 386.29%355K | -1.02%6.61M | 66.74%-4.71M | -167.58%-3.2M | 439.83%4.41M | -96.83%-124K | 224.96%6.68M | -837.19%-14.15M | 200.17%4.73M | 203.16%816K |
| -Change in other current liabilities | -25.32%-1.95M | -11.87%-1.94M | -10.38%-4.81M | -221.02%-9.16M | -365.03%-1.52M | -255.96%-1.55M | -550.65%-1.74M | -154.80%-4.35M | -38.80%7.57M | -121.52%-326K |
| -Change in other working capital | 2,150.00%123K | 101.03%8K | 68.82%-135K | -29.79%-1.51M | 92.63%-294K | 99.07%-6K | ---779K | ---433K | -29.59%-1.17M | ---3.99M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 17.93%-40.55M | 3.86%-45.5M | 31.47%-55.46M | -5.26%-218.41M | -3.53%-40.76M | 2.08%-49.41M | 23.36%-47.32M | -44.73%-80.92M | -194.80%-207.49M | -111.53%-39.37M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 30.01%50.26M | -100.49%-268K | -79.11%13.18M | 1,700.66%190.94M | 27.24%33.97M | -27.12%38.66M | 5,208.05%55.22M | 169.65%63.09M | 97.07%-11.93M | 112.34%26.7M |
| Net PPE purchase and sale | 77.35%-326K | 81.61%-474K | 88.44%-557K | 67.58%-9.96M | 79.41%-1.13M | 71.50%-1.44M | 72.10%-2.58M | 56.07%-4.82M | 63.50%-30.72M | 62.57%-5.47M |
| Net investment purchase and sale | 26.16%50.58M | -99.64%206K | -79.77%13.74M | 968.92%200.9M | 9.11%35.1M | -30.98%40.1M | 608.62%57.8M | 185.29%67.91M | 105.83%18.8M | 115.95%32.17M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 30.01%50.26M | -100.49%-268K | -79.11%13.18M | 1,700.66%190.94M | 27.24%33.97M | -27.12%38.66M | 5,208.05%55.22M | 169.65%63.09M | 97.07%-11.93M | 112.34%26.7M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -125.95%-10.86M | -3.09%-9.45M | 1,435.90%120.73M | -21.24%-34.97M | -34.10%-11.96M | 11.30%-4.81M | -19.47%-9.16M | -32.24%-9.04M | -114.77%-28.84M | -17.12%-8.92M |
| Net common stock issuance | -95.98%246K | --0 | 22,543.57%132.01M | 284.62%6.7M | --0 | 446.16%6.12M | --0 | -6.27%583K | -99.20%1.74M | --0 |
| Proceeds from stock option exercised by employees | 332.61%398K | -74.37%192K | 87.69%884K | -45.76%1.52M | 386.05%209K | -89.97%92K | -50.30%749K | 39.76%471K | -34.50%2.8M | -95.63%43K |
| Net other financing activities | -4.42%-11.5M | 2.76%-9.64M | -20.61%-12.17M | -29.36%-43.19M | -35.79%-12.17M | -47.76%-11.01M | -8.01%-9.91M | -29.49%-10.09M | -22.58%-33.39M | -4.21%-8.96M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -125.95%-10.86M | -3.09%-9.45M | 1,435.90%120.73M | -21.24%-34.97M | -34.10%-11.96M | 11.30%-4.81M | -19.47%-9.16M | -32.24%-9.04M | -114.77%-28.84M | -17.12%-8.92M |
| Net cash flow | ||||||||||
| Beginning cash position | -15.61%59.8M | 59.46%115.01M | -63.07%36.55M | -71.49%98.98M | -54.14%55.3M | -42.58%70.86M | -62.81%72.12M | -71.49%98.98M | 2.20%347.24M | -47.51%120.57M |
| Current changes in cash | 92.62%-1.15M | -4,260.98%-55.21M | 392.07%78.45M | 74.85%-62.43M | 13.17%-18.75M | -449.65%-15.56M | 98.20%-1.27M | 82.48%-26.86M | -3,417.61%-248.26M | -118.37%-21.59M |
| End cash Position | 6.05%58.65M | -15.61%59.8M | 59.46%115.01M | -63.07%36.55M | -63.07%36.55M | -54.14%55.3M | -42.58%70.86M | -62.81%72.12M | -71.49%98.98M | -71.49%98.98M |
| Free cash flow | 19.61%-40.88M | 7.87%-45.97M | 34.67%-56.01M | 4.13%-228.37M | 6.59%-41.89M | 8.40%-50.85M | 29.71%-49.9M | -28.20%-85.74M | -276.85%-238.21M | -113.72%-44.84M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Heat List
US
Overall
Symbol
Price
% Chg
No Data